metastatic-recurrent HNSCC (mHNSCC) | ||
mHNSCC - L2 - all population | mHNSCC - L2 - PDL1 positive | |
anti-PD-(L)1 | ||
durvalumab based treatment | ||
durvalumab alone | EAGLE ... | |
nivolumab based treatment | ||
nivolumab alone | CheckMate 141 | |
pembrolizumab based treatment | ||
pembrolizumab alone | KEYNOTE-040 ... | KEYNOTE-040 ... |